CILINITAB M 50 Mg : Uses, Side Effects, Dosage & More

CILINITAB M 50 Mg

Cilnidipine 10 mg & Metoprolol Succinate 50 mg

CILINITAB M 50 is a combination medication used to manage hypertension (high blood pressure) and related cardiovascular conditions. It contains two active ingredients: Cilnidipine, a calcium channel blocker, and Metoprolol Succinate, a beta-blocker. This article provides an in-depth look into CILINITAB M 50, covering its uses, dosage, side effects, composition, and more, ensuring a comprehensive understanding of this medication.

Composition

CILINITAB M 50 contains two active ingredients:

• Cilnidipine: 10 mg
• Metoprolol Succinate: 50 mg

Mechanism of Action

Cilnidipine is a calcium channel blocker that inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle cells. This action causes relaxation of the blood vessels, leading to a reduction in blood pressure and improved blood flow.

Metoprolol Succinate is a beta-blocker that works by blocking beta-adrenergic receptors in the heart. This decreases the heart rate, reduces the force of contraction, and lowers blood pressure. Together, these effects help to manage hypertension and prevent cardiovascular events.

Uses

CILINITAB M 50 is prescribed for:

• Management of hypertension (high blood pressure)
• Managing chronic stable angina (chest pain)
• Improving overall cardiovascular health

Dosage and Administration

The dosage of CILINITAB M 50 should be individualized based on the patient's condition, response to treatment, and tolerance. Typically, the recommended starting dose is:

• Cilnidipine: 10 mg once daily
• Metoprolol Succinate: 50 mg once daily

Side Effects

Like any medication, CILINITAB M 50 may cause side effects. Common side effects include:

• Dizziness or lightheadedness
• Fatigue
• Headache
• Bradycardia (slow heart rate)
• Gastrointestinal disturbances (nausea, diarrhea, constipation)

Serious but rare side effects may include:

• Severe hypotension (low blood pressure)
• Worsening of heart failure symptoms
• Shortness of breath
• Severe bradycardia
• Allergic reactions (rash, itching, swelling)

Precautions and Warnings

• Heart Conditions: Use with caution in patients with a history of heart failure, bradycardia, or conduction abnormalities.
• Renal and Liver Function: Monitor renal and liver function periodically, as both Cilnidipine and Metoprolol can affect these organs.
• Hypersensitivity: Avoid use in patients with known hypersensitivity to Cilnidipine, Metoprolol, or any component of the formulation.
• Pregnancy and Lactation: Use with caution during pregnancy and breastfeeding, as the safety of these medications in these populations has not been fully established.

Interactions

CILINITAB M 50 can interact with several medications, potentially altering their effects. Some notable interactions include:

• Other Antihypertensives: May enhance the blood pressure-lowering effects, increasing the risk of hypotension.
• Beta-Agonists: May reduce the effectiveness of beta-agonists such as albuterol.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): May reduce the antihypertensive effect of Cilnidipine and Metoprolol.
• Antidiabetic Medications: May mask the symptoms of hypoglycemia.

Monitoring

Regular monitoring is crucial to ensure the safe and effective use of CILINITAB M 50:

• Blood Pressure: Regular monitoring helps assess the efficacy of the medication.
• Heart Rate: Monitor to detect bradycardia early.
• Renal and Liver Function: Periodic assessment of renal and liver function is necessary to detect any potential adverse effects.

Lifestyle and Dietary Recommendations

• Diet: Follow a balanced diet low in sodium and saturated fats to support blood pressure control. Incorporate plenty of fruits, vegetables, whole grains, and lean proteins.
• Exercise: Regular physical activity helps improve cardiovascular health and manage blood pressure.
• Hydration: Maintain adequate fluid intake to support overall health.

Conclusion

CILINITAB M 50, combining Cilnidipine and Metoprolol Succinate, offers an effective solution for managing hypertension and improving cardiovascular health. Always consult with a healthcare provider for personalized advice and monitoring while using this medication. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW